Siegfried AG

Catalent, Inc ’s big response to the COVID-19 pandemic proved its undoing, with the contract development and manufacturing organization’s eventual acquisition now pending by client Novo Nordisk A/S .

Catalent, Inc ’s big response to the COVID-19 pandemic proved its undoing, with the contract development and manufacturing organization’s eventual acquisition now pending by client Novo Nordisk A/S .

“Switzerland has four main sources of new biotech activity,” Swiss Biotech Association CEO Michael Altorfer told Scrip . “The first source is spin-offs from academic centres in the country, the secon

CNS specialist Neuraxpharm has appointed Philipp Pohoralek as the company’s new commercial central region officer and country manager for Germany from the start of September. He will focus on streng